A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 174
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : TIPSS
Long Form : transjugular intrahepatic portosystemic stent shunt
No. Year Title Co-occurring Abbreviation
2020 Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension. BASL, BSG, BSIR, CSSC
2019 L-Ornithine L-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses. HE, LOLA, MHE, OHE, RCTs
2019 TIPSS for variceal bleeding in patients with idiopathic non-cirrhotic portal hypertension: comparison with patients who have cirrhosis. INCPH
2019 Unsolved Questions in Salvage TIPSS: Practical Modalities for Placement, Alternative Therapeutics, and Long-Term Outcomes. ---
2018 Clinical Experience with Real-Time 3-D Guidance Based on C-Arm-Acquired Cone-Beam CT (CBCT) in Transjugular Intrahepatic Portosystemic Stent Shunt (TIPSS) Placement. CBCT, CBCT, US
2018 Combined diffusion tensor imaging and magnetic resonance spectroscopy to predict neurological outcome before transjugular intrahepatic portosystemic shunt. DTI, HE, MRI
2018 Erratum: Lipopolysaccharide-Induced Neutrophil Dysfunction Following Transjugular Intrahepatic Portosystemic Stent Shunt (TIPSS) Insertion is Associated with Organ Failure and Mortality. ---
2018 Excellent long-term outcomes of endovascular treatment in budd-chiari syndrome with hepatic veins involvement: A STROBE-compliant article. BCS, PTBA
2018 Long-term outcome of transjugular intrahepatic portosystemic shunt for portal hypertension in autosomal recessive polycystic kidney disease. ARPKD, CHF
10  2018 Portal Hypertensive Colopathy with Pelvic Varices presenting as Severe Lower GI Bleed treated with TIPSS. GI, SMV
11  2018 Portal Vein Thrombosis in Patients With Cirrhosis Undergoing Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors, Warfarin Efficacy, and Clinical Outcomes. CI, PVT, RR
12  2018 Resolution of refractory hepatic hydrothorax in patients with hepatitis C virus cirrhosis after treatment with direct-acting antiviral agents. DAAs, HCV, HH, RHH
13  2018 Transjugular Intrahepatic Portosystemic Shunt Insertion for the Management of Portal Hypertension in Children. CI, LR, PHTN
14  2017 Bleeding ectopic duodenal varix: use of a new microvascular plug (MVP) device along with transjugular intrahepatic portosystemic shunt (TIPSS). DV, EcV, GI, MVP
15  2017 Corrigendum: Lipopolysaccharide-Induced Neutrophil Dysfunction Following Transjugular Intrahepatic Portosystemic Stent Shunt (TIPSS) Insertion is Associated with Organ Failure and Mortality. ---
16  2017 Effects of a Long-Acting Formulation of Octreotide on Patients with Portal Hypertension. ET-1, HVPG
17  2017 Endovascular treatment of Budd-Chiari syndrome: Single center experience. BCS, IVC
18  2017 Lipopolysaccharide-Induced Neutrophil Dysfunction Following Transjugular Intrahepatic Portosystemic Stent Shunt (TIPSS) Insertion is Associated with Organ Failure and Mortality. HV, LPS, PV, ROS
19  2017 Modern Management Of Duodenal Variceal Bleeding. BRTO
20  2017 Outcomes of surgical shunts and transjugular intrahepatic portasystemic stent shunts for complicated portal hypertension. MELD
21  2017 Recanalization of TIPSS via transsplenic puncture. BCS
22  2017 Short outcome comparison of elderly patients versus nonelderly patients treated with transjugular intrahepatic portosystemic stent shunt: A propensity score matched cohort study. RB
23  2017 Treatment of refractory ascites with an automated low-flow ascites pump in patients with cirrhosis. RA
24  2016 Balloon-Occluded Retrograde Transvenous Obliteration (BRTO): A Novel Method of Control of Bleeding from Post-Glue Ulcer over Gastric Varices. Report of Two Cases and Review of Literature. BRTO, GV
25  2016 Cardiac volume overload and pulmonary hypertension in long-term follow-up of patients with a transjugular intrahepatic portosystemic shunt. IQR, LAD, LVEDd, PASP, PH
26  2016 Implantability, Complications, and Follow-Up After Transjugular Intrahepatic Portosystemic Stent-Shunt Creation With the 6F Self-Expanding Sinus-SuperFlex-Visual Stent. OLT
27  2016 Pharmacomechanical thrombectomy for salvage of TIPSS via successful -clearance of occlusive porto-splenic venous thrombosis. ---
28  2016 Procedural and shunt-related complications and mortality of the transjugular intrahepatic portosystemic shunt (TIPSS). ---
29  2015 A retrospective analysis of the impact of diastolic dysfunction on one-year mortality after transjugular intrahepatic porto-systemic shunt, liver transplantation and non-transplant abdominal surgery in patients with cirrhosis. DD
30  2015 Early transjugular intrahepatic portosystemic shunt in cirrhotic patients with acute variceal bleeding: a systematic review and meta-analysis of controlled trials. AVB, CI, OR
31  2015 Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma. HCC
32  2015 Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma in Patients with Transjugular Intrahepatic Portosystemic Shunts. HCC, RF
33  2015 Transjugular intrahepatic portosystemic shunt versus surgical shunting in the management of portal hypertension. CI, OR, RCTs
34  2015 Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: A systematic review and cumulative meta-analysis. RHH
35  2014 Clinical and prothrombotic profile of hepatic vein outflow tract obstruction. CT, HVOTO, IVC, MDCT, MTHFR
36  2014 Establishment of trigger levels to steer the follow-up of radiation effects in patients undergoing fluoroscopically-guided interventional procedures in Belgium. KAP
37  2014 Folic acid handling by the human gut: implications for food fortification and supplementation. 5-FormylTHF, 5-MTHF, DHFR
38  2014 Good clinical outcomes following transjugular intrahepatic portosystemic stent-shunts in Budd-Chiari syndrome. BCS, MELD, PTFE
39  2014 Outcomes of endoscopic human thrombin injection in the management of gastric varices. ---
40  2014 Technical concepts for vascular electromagnetic navigated interventions: aortic in situ fenestration and transjugular intrahepatic porto-systemic shunts. EMT
41  2013 A case-control study of transjugular intrahepatic portosystemic stent shunts for patients admitted to intensive care following variceal bleeding. CI, MELD
42  2013 Diffusion-weighted imaging (DWI) of the spleen in patients with liver cirrhosis and portal hypertension. ADC, DWI
43  2013 Elevated cardiac markers are associated with higher mortality in patients after transjugular intrahepatic portosystemic shunt insertion. FABP, GPBB, hs-cTnT, MYO
44  2012 Human thrombin for the treatment of gastric and ectopic varices. ---
45  2012 Midterm follow-up of transjugular intrahepatic portosystemic shunts using polytetrafluoroethylene endografts in children. ePTFE
46  2012 The role of Transjugular Intrahepatic Portosystemic Stent-Shunt (TIPSS) in the management of variceal hemorrhage. ---
47  2012 Transjugular intrahepatic portosystemic shunt creation using intravascular ultrasound guidance. PV, US
48  2011 Influence of the secondary deployment of expanded polytetrafluoroethylene-covered stent grafts on maintenance of transjugular intrahepatic portosystemic shunt patency. ePTFE
49  2011 Regional variations in the concentrations of ketone bodies in cirrhosis and hepatic encephalopathy: a study in patients with TIPSS. ---
50  2010 Stent-grafts for transjugular intrahepatic portosystemic shunt creation: specialized TIPS stent-graft versus generic stent-graft/bare stent combination. PSG
51  2010 Tipsitis: incidence and outcome-a single centre experience. ---
52  2010 Transjugular intrahepatic portosystemic shunt (TIPSS) for Budd Chiari syndrome. ---
53  2010 Transjugular intrahepatic portosystemic shunt with accidental diagnosis of persistence of the left superior vena cava. ---
54  2009 A new alternative for a transjugular intrahepatic portosystemic shunt: EUS-guided creation of an intrahepatic portosystemic shunt (with video). HV, IPSS, PV
55  2009 Emergency liver transplantation after umbilical hernia repair: a case report. ---
56  2009 Transjugular intrahepatic portosystemic shunt in liver transplant recipients. LT
57  2009 Transjugular intrahepatic portosystemic stenting in Portal Hypertensive Gastropathy. CLD, EGD, HCV, PHG
58  2008 Acute liver failure after a late TIPSS revision. ---
59  2008 Bleeding ectopic varices in cirrhosis: the role of transjugular intrahepatic portosystemic stent shunts. ---
60  2008 Measuring the effect of a study meal on portal concentrations of glucagon-like peptide 1 (GLP-1) in non diabetic and diabetic patients with liver cirrhosis: transjugular intrahepatic portosystemic stent shunt (TIPSS) as a new method for metabolic measurements. GLP-1, ND
61  2008 TIPSS procedure in the treatment of a single patient after recent heart transplantation because of refractory ascites due to cardiac cirrhosis. ---
62  2007 A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. ---
63  2007 Acute upper gastrointestinal haemorrhage. ---
64  2007 Aromatic amino acid metabolism during liver failure. AAA, BCAA, HE
65  2007 Prevalence of gastric varices and results of sclerotherapy with N-butyl 2 cyanoacrylate for controlling acute gastric variceal bleeding. GI, GOV, GV, IGV-I
66  2007 Treating bleeding oesophageal varices with vasoactive agents: good value for money? ---
67  2007 [Case report: massive lower intestinal bleeding from ileal varices: treatment with transjugular intrahepatic portosystemic shunt (TIPSS)]. ---
68  2006 Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents. CI, RH
69  2006 Percutaneous transjugular direct porto-caval shunt in patients with Budd-Chiari syndrome. BCS, IVC
70  2006 TIPSS for variceal hemorrhage after living related liver transplantation: a dangerous indication. LDLT
71  2006 Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy. HE
72  2006 Transjugular intrahepatic portosystemic stent-shunt: technical factors and new developments. ---
73  2005 Quantification of changes in electroencephalographic power spectra in a patient with Budd-Chiari-syndrome after implantation of a transjugular intrahepatic portosystemic stent shunt (TIPSS). BCS, CNS, EEG
74  2005 Transjugular intrahepatic portosystemic stent shunt: 11 years' experience at a regional referral centre. ---
75  2005 [Budd-Chiari syndrome in a patient with paroxysmal nocturnal haemoglobinuria]. PNH
76  2004 Cardiopulmonary consequences of transjugular intrahepatic portosystemic shunts: role of increased pulmonary artery pressure. PAP
77  2004 Covered transjugular intrahepatic portosystemic stents maintain lower portal pressure and require fewer reinterventions than uncovered stents. ePTFE, PCPG
78  2004 Randomised controlled trial of long term portographic follow up versus variceal band ligation following transjugular intrahepatic portosystemic stent shunt for preventing oesophageal variceal rebleeding. CI, VBL
79  2004 Ten years' follow-up of 472 patients following transjugular intrahepatic portosystemic stent-shunt insertion at a single centre. ---
80  2004 Treatment of refractory post-transjugular portosystemic stent-shunt encephalopathy: a novel case of stent luminal reduction. ---
81  2003 Oral anticoagulants as secondary prophylaxis of thrombosis in patients with polycythemia vera: a retrospective analysis of 15 patients. OA, PV
82  2003 Review article: the management of acute variceal bleeding. ---
83  2003 Systemic and regional changes in plasma endothelin following transient increase in portal pressure. CO, HPF, PPG, RPF, SVR, V-A
84  2003 The kidney plays a major role in the hyperammonemia seen after simulated or actual GI bleeding in patients with cirrhosis. UGI
85  2002 Impact of transjugular intrahepatic portosystemic stent-shunt for secondary prophylaxis of oesophageal variceal haemorrhage: a single-centre study over an 11-year period. EVS, VBL
86  2002 Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS. PDV
87  2002 Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt. ---
88  2002 Prognostic factors of the long-term survival after transjugular intrahepatic portosystemic shunt in the treatment of gastric and esophageal variceal bleeding. ---
89  2002 Prospective evaluation of a clinical score for 60-day mortality after transjugular intrahepatic portosystemic stent-shunt: Bonn TIPSS early mortality analysis. APACHE, BOTEM
90  2002 Quantification of the electroencephalographic theta/alpha ratio for the assessment of portal-systemic encephalopathy following implantation of transjugular intrahepatic portosystemic stent shunt (TIPSS). EEG
91  2002 Restoration of liver function and portosystemic pressure gradient after TIPSS and late TIPSS occlusion. ---
92  2002 The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. PPG
93  2002 Transjugular intrahepatic portosystemic shunt for liver transplantation. ---
94  2002 Transjugular intrahepatic portosystemic stent-shunt and its effects on orthotopic liver transplantation. ---
95  2001 A new stent-graft for transjugular intrahepatic portosystemic shunts. ---
96  2001 Transjugular intrahepatic portosystemic stent-shunt insufficiency and the role of diabetes mellitus. ---
97  2001 [Veno-occlusive liver disease after total infradiaphragmatic lymphoid irradiation. A rare complication]. VOD
98  2000 Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. ---
99  2000 Endoscopic treatment of oesophageal varices. ---
100  2000 Liver transplantation in patients with transjugular intrahepatic portosystemic shunts. ANLTU